MimiVax LLC

MimiVax is a biotech startup with exclusive license to commercialize SurVaxM, a new vaccine to treat cancer.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Buffalo, NY, USA
  • Currency USD
  • Website mimivax.com

Company Summary

Team

  • Robert Fenstermaker
    Co-Founder and CMO

  • Michael Ciesielski
    Co-Founder and CSO

  • Scott Friedman
    Co-Founder

  • Robert Fenstermaker

Advisors

  • Scott Friedman, Esq
    Lawyer
    Unconfirmed
    Michael Songin
    Accountant
    Unconfirmed

Previous Investors

  • All funding to date has been from non-dilutive grant support
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free